State Street’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.2M Sell
2,948,808
-265,448
-8% -$2.45M ﹤0.01% 2017
2025
Q1
$27.6M Buy
3,214,256
+802,327
+33% +$6.88M ﹤0.01% 1951
2024
Q4
$25.9M Sell
2,411,929
-654,018
-21% -$7.02M ﹤0.01% 2078
2024
Q3
$17.4M Sell
3,065,947
-674,409
-18% -$3.83M ﹤0.01% 2291
2024
Q2
$15.8M Sell
3,740,356
-3,558,651
-49% -$15M ﹤0.01% 2289
2024
Q1
$37.2M Buy
7,299,007
+3,656,305
+100% +$18.6M ﹤0.01% 1877
2023
Q4
$33.9M Buy
3,642,702
+17,253
+0.5% +$161K ﹤0.01% 1912
2023
Q3
$23.7M Sell
3,625,449
-783,488
-18% -$5.13M ﹤0.01% 2059
2023
Q2
$35.8M Sell
4,408,937
-1,268,439
-22% -$10.3M ﹤0.01% 1864
2023
Q1
$48.7M Sell
5,677,376
-135,229
-2% -$1.16M ﹤0.01% 1668
2022
Q4
$53.8M Buy
5,812,605
+1,451,167
+33% +$13.4M ﹤0.01% 1584
2022
Q3
$45M Sell
4,361,438
-127,807
-3% -$1.32M ﹤0.01% 1658
2022
Q2
$44.9M Sell
4,489,245
-1,088,011
-20% -$10.9M ﹤0.01% 1721
2022
Q1
$68.7M Buy
5,577,256
+1,743,222
+45% +$21.5M ﹤0.01% 1562
2021
Q4
$66.5M Sell
3,834,034
-331,386
-8% -$5.75M ﹤0.01% 1608
2021
Q3
$74.8M Buy
4,165,420
+93,447
+2% +$1.68M ﹤0.01% 1500
2021
Q2
$93.1M Buy
4,071,973
+1,324,794
+48% +$30.3M ﹤0.01% 1354
2021
Q1
$41.1M Buy
2,747,179
+1,872,614
+214% +$28M ﹤0.01% 1891
2020
Q4
$4.72M Sell
874,565
-15,925
-2% -$86K ﹤0.01% 2992
2020
Q3
$4.05M Buy
890,490
+14,119
+2% +$64.2K ﹤0.01% 2882
2020
Q2
$4.31M Buy
876,371
+53,594
+7% +$264K ﹤0.01% 2830
2020
Q1
$2.59M Buy
822,777
+14,767
+2% +$46.5K ﹤0.01% 2943
2019
Q4
$2.09M Buy
808,010
+24,084
+3% +$62.4K ﹤0.01% 3233
2019
Q3
$2.48M Buy
783,926
+149,644
+24% +$473K ﹤0.01% 3141
2019
Q2
$2.14M Buy
634,282
+581,621
+1,104% +$1.96M ﹤0.01% 3217
2019
Q1
$161K Sell
52,661
-1,143
-2% -$3.49K ﹤0.01% 3594
2018
Q4
$84K Sell
53,804
-1,362
-2% -$2.13K ﹤0.01% 3647
2018
Q3
$151K Sell
55,166
-17,057
-24% -$46.7K ﹤0.01% 3619
2018
Q2
$189K Sell
72,223
-593,610
-89% -$1.55M ﹤0.01% 3574
2018
Q1
$1.84M Buy
665,833
+41,194
+7% +$114K ﹤0.01% 3203
2017
Q4
$2.01M Buy
624,639
+17,459
+3% +$56.2K ﹤0.01% 3181
2017
Q3
$2.52M Buy
607,180
+3,854
+0.6% +$16K ﹤0.01% 3109
2017
Q2
$3.21M Buy
603,326
+79,516
+15% +$423K ﹤0.01% 2935
2017
Q1
$3.01M Buy
523,810
+132,745
+34% +$762K ﹤0.01% 2935
2016
Q4
$1.55M Buy
391,065
+83,716
+27% +$332K ﹤0.01% 3184
2016
Q3
$1.11M Buy
307,349
+218,377
+245% +$792K ﹤0.01% 3162
2016
Q2
$544K Buy
88,972
+69,172
+349% +$423K ﹤0.01% 3378
2016
Q1
$97K Buy
19,800
+1,200
+6% +$5.88K ﹤0.01% 3560
2015
Q4
$103K Buy
+18,600
New +$103K ﹤0.01% 3548